Cargando…

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy

AIMS: Tafamidis improves prognosis in patients with transthyretin amyloid cardiomyopathy (ATTR‐CM). However, real‐world data on the therapeutic effect of tafamidis are lacking. This study aimed to evaluate the clinical course, outcomes, and effectivity monitoring of the therapeutic effect of tafamid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takashio, Seiji, Morioka, Mami, Ishii, Masanobu, Morikawa, Kei, Hirakawa, Kyoko, Hanatani, Shinsuke, Oike, Fumi, Usuku, Hiroki, Kidoh, Masafumi, Oda, Seitaro, Yamamoto, Eiichiro, Matsushita, Kenichi, Ueda, Mitsuharu, Tsujita, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375127/ https://www.ncbi.nlm.nih.gov/pubmed/37073415 http://dx.doi.org/10.1002/ehf2.14380

Ejemplares similares

Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild‐Type Transthyretin Amyloid Cardiomyopathy
por: Morioka, Mami, et al.
Publicado: (2022)

Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2023)

Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2022)

Prognostic value of left atrial strain in patients with wild‐type transthyretin amyloid cardiomyopathy
por: Oike, Fumi, et al.
Publicado: (2021)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
por: Oike, Fumi, et al.
Publicado: (2022)

A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Nakashima, Naoya, et al.
Publicado: (2022)

Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Yamada, Toshihiro, et al.
Publicado: (2020)

Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
por: Egashira, Koichi, et al.
Publicado: (2022)

Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
por: Hirakawa, Kyoko, et al.
Publicado: (2018)

Anti-Kv1.4 Antibody Without Myasthenia Gravis: A Rare Cause of Autoimmune Myocarditis and Myositis
por: Kuyama, Naoto, et al.
Publicado: (2023)

Dynamic evaluation of myocardial extracellular volume fraction using dual-layer spectral detector computed tomography
por: Kidoh, Masafumi, et al.
Publicado: (2020)

Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2023)

Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
por: Egashira, Koichi, et al.
Publicado: (2021)

Temporal Change in Longitudinal Strain After Domino Liver Transplantation With Liver Grafts Explanted From Patients With Hereditary Amyloidogenic Transthyretin Amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2020)

Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy
por: Kawahara, Yusei, et al.
Publicado: (2023)

HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
por: Egashira, Koichi, et al.
Publicado: (2022)

Prognostic significance of liver stiffness assessed by fibrosis‐4 index in patients with heart failure
por: Takae, Masafumi, et al.
Publicado: (2021)

A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers
por: Fujisue, Koichiro, et al.
Publicado: (2022)

Dynamic change of mitral regurgitation after myocardial reverse remodelling: a case report
por: Morioka, Mami, et al.
Publicado: (2022)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?
por: Hayashi, Hidetaka, et al.
Publicado: (2021)

Wild-type transthyretin amyloid cardiomyopathy complicated by spinal canal stenosis, carpal tunnel syndrome, and rotator cuff tears: a case report
por: Takashio, Seiji, et al.
Publicado: (2020)

Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
por: Ogasawara, Kouji, et al.
Publicado: (2022)

Coefficient of R‐R interval variations under deep breathing load in patients with wild‐type transthyretin amyloid cardiomyopathy: A case‐control study
por: Nagayoshi, Yasuhiro, et al.
Publicado: (2022)

Double‐chambered right ventricle complicated by hypertrophic obstructive cardiomyopathy diagnosed as Noonan syndrome
por: Yamamoto, Masahiro, et al.
Publicado: (2020)

Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
por: Li, Benjamin, et al.
Publicado: (2020)

Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction
por: Nishihara, Taiki, et al.
Publicado: (2019)

Multiple focal atrial tachycardia as a characteristic finding of intractable arrhythmia associated with wild-type transthyretin amyloid cardiomyopathy
por: Kanazawa, Hisanori, et al.
Publicado: (2022)

Successful treatment of deep vein thrombosis caused by iliac vein compression syndrome with a single-dose direct oral anti-coagulant
por: Nakashima, Naoya, et al.
Publicado: (2017)

Extensive Loss of Myocardium due to Lymphocytic Fulminant Myocarditis: An Autopsy Case Report of a Patient with Persistent Cardiac Arrest for 25 Days
por: Morikawa, Kei, et al.
Publicado: (2020)

A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis
por: Waddington Cruz, Márcia, et al.
Publicado: (2015)

Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
por: Romero-Imbroda, Jesús, et al.
Publicado: (2017)

Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy
por: Nakamura, Makiko, et al.
Publicado: (2020)

The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction
por: Komorita, Takashi, et al.
Publicado: (2020)

Multiple Giant Coronary Artery Aneurysms
por: Usuku, Hiroki, et al.
Publicado: (2017)

Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis
por: Okada, Masamitsu, et al.
Publicado: (2020)

Effect of contact vector direction on achieving cavotricuspid isthmus block
por: Sumi, Hitoshi, et al.
Publicado: (2023)

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy
por: Falk, Rodney H., et al.
Publicado: (2021)

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction
por: Fujisue, Koichiro, et al.
Publicado: (2019)

Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis
por: Coelho, Teresa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k3tr4m3eoocte4adodpp2se74a